Sequoia Capital China backs $16m round for biotech company Cullgen

Photo by Louis Reed on Unsplash

Sequoia Capital China has participated in a $16-million Series A round for US-based drug discovery company Cullgen Inc, according to a statement.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.